© 2020 MJH Life Sciences and HCPLive. All rights reserved.
Diabetes
DDP-4 Inhibitors Increase Risk of Bullous Pemphigoid
August 05, 2020
Article
Older, white patients and those who use linagliptin are at a higher risk of bullous pemphigoid.
Moderate to Severe NPDR Leads to Greater Risk of Vision-Threatening DR
July 28, 2020
Article
Eyes with moderate to severe nonproliferative diabetic retinopathy more often develop eye worsening compared to those with a milder form of the condition.
Telescreening Programs Could Help Identify the Rates of Retinal Pathology
July 28, 2020
Article
A total of 115 of 200 examined eyes had some form of diabetic retinopathy in data presented at the ASRS 2020 virtual meeting.
Factors Associated with Blindness in Patients with Type 2 Diabetes
July 27, 2020
Article
The findings of the study highlight the importance of screening eye exams from index diagnosis.
What Is the Cross-Specialty Collaboration for Retina Disease?
July 26, 2020
Video
A look at how the specialty functions in telemedicine, and how it could work better with primary care physicians and endocrinologists.
How Diabetics Progress to Retina Complications
July 25, 2020
Video
A look at how primary care patients begin to present with diabetic retinopathy risk.
Cataract Surgery Increases Risk of Diabetic Retinopathy
July 20, 2020
Article
Cataracts and diabetic retinopathy are the 2 leading causes of acquired blindness worldwide.
New Report Highlights National COVID-19 Patient Characteristics
July 15, 2020
Article
Chronic kidney disease and kidney failure represent the most common comorbidities for patients hospitalized with COVID-19 infections.
Study Identifies Potential Type 2 Diabetes plus Dry Eye Biomarkers
July 05, 2020
Article
New research shows patients with both conditions have greater levels of particular cytokines and metabolic proteins.
Comparing Diabetes Therapies in Patients with Low versus Increased CV Risk
June 30, 2020
Article
A systematic review and network meta-analysis is comparing 9 classes of therapies for HbA1c and risk management in patients with low versus increased cardiovascular risk.